載入...
The Prenylflavonoid Xanthohumol Reduces Alzheimer-Like Changes and Modulates Multiple Pathogenic Molecular Pathways in the Neuro2a/APP(swe) Cell Model of AD
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that has proved refractory to drug treatment. Given evidence of neuroprotection in animal models of ischemic stroke, we assessed the prenylflavonoid xanthohumol from the Common Hop (Humulus lupulus L.) for therapeutic potential in...
Na minha lista:
| 發表在: | Front Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5893754/ https://ncbi.nlm.nih.gov/pubmed/29670521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00199 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|